Clinical Trial

Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease

Name: Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease — clinical trial record (NCT07262476)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This is a multicenter, open-label extension (OLE) study of MHB018A in subjects with moderate-to-severe TED.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-12-01.

Status change: Not Yet Recruiting → Recruiting 2026-03-27

Trial Details

NCT Number	NCT07262476
Lead Sponsor	Minghui Pharmaceutical (Hangzhou) Ltd
Conditions	Thyroid Eye Disease (TED)
Enrollment	258 participants
Start Date	2026-01-09
Primary Completion	2029-01-31 (estimated)
Study Completion	2030-01-31 (estimated)
Updated on ClinicalTrials.gov	2026-03-30